Objective and Scope:

The client, a leading PE firm, wanted to conduct commercial due diligence (CDD) for one of its portfolio companies operating in the healthcare domain. The focus of this exercise was on a Real-World Evidence (RWE) solution. For this, the client sought Benori’s support to understand:

• The total addressable market of RWE solutions and market growth drivers, including a regulatory push from the FDA to include RWE in submissions made to them
• The key reasons for outsourcing RWE activities and the key buyers of these solutions
• The competitive landscape and recent M&As in the industry

Approach:

Benori conducted in-depth secondary research to collate, validate, and triangulate the information required for estimating the market size of the RWE industry in different categories. We identified key growth drivers, inhibitors, recent trends, and regulatory developments. In addition, we conducted multiple expert interviews to validate the information on the total addressable market size and prospects of the industry.

Impact:

The study helped the client to proceed with the acquisition as they gained an understanding in:

• Overview of the RWE industry and its addressable market
• Key growth drivers and detractors of the industry and regulatory changes impacting the deal scenario
• Competitive landscape and the impact of COVID-19 on the industry